InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,599.04
(
0.40%
)
US TECH 100
19,994.40
(
0.42%
)
Dow Jones
39,398.08
(
0.27%
)
Brent Oil
85.14
(
0.52%
)
Bitcoin
57,882.41
(
-0.24%
)
Post# of 12660
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

walldiver

Send PM Follow Ignore
Followers 24
Posts 1614
Boards Moderated 0
Alias Born 01/02/2003

walldiver

Re: headless post# 4968

Monday, 10/29/2007 8:15:29 PM

Monday, October 29, 2007 8:15:29 PM

Post# of 12660
I'm sure that there are plenty of DNDN investors who will respond that while survival wasn't an official endpoint, it was prespecified, and the FDA's briefing document reviewer stated that survival is the one metric that is valued highly enough that even if it isn't an official endpoint in a trial, the FDA always treats it seriously.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up